<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Ribose 5-Phosphate Isomerase B Knockdown <br /> Compromises Trypanosoma brucei Bloodstream Form <br /> Infectivity <br /> Ine&#203;&#8224;s Loureiro1, Joana Faria1, Christine Clayton2, Sandra Macedo-Ribeiro3, Nuno Santare&#194;&#180;m1, <br /> Nilanjan Roy4, Anabela Cordeiro-da-Siva1,5`*, Joana Tavares1`* <br /> 1 Parasite Disease Group, Instituto Biologia Molecular e Celular da Universidade Porto, Porto, Portugal, 2 Zentrum fu&#194;&#168;r Molekulare Biologie der Universita&#194;&#168;t <br /> Heidelberg, DKFZ-ZMBH cv Alliance, Heidelberg, Germany, 3 Protein Crystallography Group, Instituto Biologia Molecular e Celular da Universidade Porto, Porto, <br /> Portugal, 4 Ashok &amp; Rita Patel Institute Integrated Study &amp; Research Biotechnology &amp; Allied Sciences, New Vallabh Vidyanagar, Dist-Anand, Gujarat, India, <br /> 5 Departamento Cie&#203;&#8224;ncias Biolo&#194;&#180;gicas, Faculdade Farma&#194;&#180;cia da Universidade Porto, Porto, Portugal <br />  <br />  <br />  <br />      <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />      Ribose 5-phosphate isomerase enzyme involved non-oxidative branch pentose phosphate pathway, and <br />      catalyzes inter-conversion D-ribose 5-phosphate D-ribulose 5-phosphate. Trypanosomatids, including agent <br />      African sleeping sickness Trypanosoma brucei, type B ribose-5-phosphate isomerase. This enzyme absent <br />      humans, structurally unrelated ribose 5-phosphate isomerase type A, proposed <br />      attractive drug target waiting characterization. In study, Trypanosoma brucei ribose 5-phosphate isomerase <br />      B showed vitro isomerase activity. RNAi enzyme reduced parasites&#226;&#8364;&#8482; vitro growth, importantly, <br />      bloodstream forms infectivity. Mice infected induced RNAi clones exhibited lower parasitaemia prolonged <br />      <span id='am-7' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-8' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-33' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-48' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-81' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-83' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span>survival</span> compared control mice. Phenotypic reversion achieved complementing induced RNAi clones an <br />      ectopic copy Trypanosoma cruzi gene. Our results present functional characterization Trypanosoma brucei <br />      ribose 5-phosphate isomerase B, relevance enzyme belonging non-oxidative branch the <br />      pentose phosphate pathway context Trypanosoma brucei infection. <br />  <br />   Citation: Loureiro I, Faria J, Clayton C, Macedo-Ribeiro S, Santare&#194;&#180;m N, et al. (2015) Ribose 5-Phosphate Isomerase B Knockdown Compromises Trypanosoma <br />   brucei Bloodstream Form Infectivity. PLoS Negl Trop Dis 9(1): e3430. doi:10.1371/journal.pntd.0003430 <br />   Editor: Michael P. Pollastri, Northeastern University, United States America <br />   Received July 25, 2014; Accepted November 21, 2014; Published January 8, 2015 <br />   Copyright:   2015 Loureiro et al. This open-access article distributed terms Creative Commons Attribution License, permits <br />   unrestricted use, distribution, reproduction medium, provided original author source credited. <br />   Data Availability: The authors confirm data underlying findings fully available restriction. All relevant data paper its <br />   Supporting Information files sequence TbRpiB, TcRpiB CL Brener Esmeraldo-like non-Esmeraldo-like available <span id='am-4' about='protege:FROM' typeof='owl:Thing'>from</span> <br />   TriTrypdb.org accession numbers Tb927.11.8970, Tc00.1047053509199.24 Tc00.1047053508601.119 respectively. <br />   Funding: This work funded European Community&#226;&#8364;&#8482;s Seventh Framework Programme grant agreement No. 602773 (Project KINDRED). The COST <br />   Action CM1307 &#226;&#8364;&#732;Targeted chemotherapy diseases caused endoparasites&#226;&#8364;&#8482; FEDER funds Operational Competitiveness Program &#226;&#8364;&#8220; <br />   COMPETE National Funds FCT &#226;&#8364;&#8220; Fundac&#194;&#184;a&#203;&#339;o para Cie&#203;&#8224;ncia e Tecnologia project PEst-C/SAU/LA0002/2011 contributed this <br />   work. IL JF supported fellowships FCT reference SFRH/BD/64528/2009 SFRH/BD/79712/2011, respectively. NS supported fellowship <br />   European Community&#226;&#8364;&#8482;s Seventh Framework Programme grant agreement No. 602773 (Project KINDRED). JT Investigator FCT funded by <br />   National funds FCT co-funded European Social Fund Human Potential Operating Programme. The funders role study <br />   design, data collection analysis, decision publish, preparation manuscript. <br />   Competing Interests: The authors declared competing interests exist. <br />   * cordeiro@ibmc.up.pt (ACdS); jtavares@ibmc.up.pt (JT) <br />   ` These authors contributed equally work. <br />  <br />  <br />  <br />  <br /> Introduction                                                                            PPP includes oxidative branch, mainly involved the <br />                                                                                         maintenance cell redox homeostasis, non-oxidative <br />    African sleeping sickness vector borne disease mammals,                      branch ribose 5-phosphate produced nucleotide <br /> caused Trypanosoma brucei (T. brucei),                                 nucleic acid synthesis. Enzymes involved PPP non- <br /> development effective, safe, affordable chemothera-                         oxidative branch include ribose-5-phosphate isomerase, ribulose- <br /> pies remains major goal. Vaccines unlikely suitable [1&#226;&#8364;&#8220;                     5-phosphate epimerase, transaldolase transketolase, in <br /> 3], disease control relies exclusively chemother-                      contrast enzymes involved glycolysis [6&#226;&#8364;&#8220;15] the <br /> apy. The glucose-based metabolism key metabolic pathway                        oxidative PPP [16,17], studied. In T. brucei, <br /> bloodstream forms, mammalian infective stages. The absence                          enzymes non-oxidative branch downstream ribose-5- <br /> of fully functional mitochondrion remarkable high                        phosphate isomerase apparently developmentally regulated <br /> proliferation rate makes parasites entirely dependent glucose                        [18]. Ribose 5-phosphate epimerase transketolase activities <br /> [4,5]. The glucose-based metabolism comprises pathways:                         detected procyclics, parasite form present the <br /> glycolytic pathway pentose phosphate pathway (PPP).                             insect vector. This suggests mammalian host, <br /> Despite using substrate, pathways different                           bloodstream forms constrain sugar metabolism production <br /> functions. Glycolysis catabolizes glucose ATP requirements,                         ribose-5-phosphate NADPH oxidative phase the <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                                 1                                 January 2015 | Volume 9 | Issue 1 | e3430 <br />                                                                                                 Trypanosoma brucei Ribose 5-Phosphate Isomerase B <br />  <br />  <br />  <br />   Author Summary                                                               primer 59 - CCCAAGCGAATTCTCATTTTACCCCTTTG - <br />                                                                                39, respectively. PCR conditions follows: initial denatur- <br />   Within non-oxidative branch pentose phosphate                     ation (2 min 94uC), 35 cycles denaturation (30 s 94uC), <br />   pathway, ribose 5-phosphate isomerase catalyzes                          annealing (30 s 40uC) elongation (2 min 68uC) followed <br />   inter-conversion ribose 5-phosphate ribulose 5-                       final extension step (10 min 68uC); initial denaturation <br />   phosphate. There types ribose 5-phosphate                         (2 min 94uC), 35 cycles denaturation (30 s 94uC), <br />   isomerase, A B. The presence type B                         annealing (30 s 58uC) elongation (2 min 68uC) final <br />   Trypanosoma brucei, absence humans, make                     extension step (10 min 68uC), respectively. The PCR products <br />   protein promising drug target. African sleeping sickness                   isolated 1% agarose gel, purified Qiaex II <br />   parasitic disease relies limited                        protocol (Qiagen), cloned pGEM-T Easy vector <br />   chemotherapeutic options control. In study, a <br />                                                                                (Promega) sent Eurofins MWG (Germany) sequencing. <br />   functional characterization Trypanosoma brucei ribose 5- <br />   phosphate isomerase B reported. Biochemical studies                       All fragments checked T. brucei T. cruzi <br />   confirmed enzyme isomerase activity downregula-                      genome sequence database (http://www.genedb.org) using Blast <br />   tion RNAi affected mainly parasites infectivity vivo.                  ensure specificity. <br />   Overall study shows ribose 5-phosphate isomer- <br />   ase depletion detrimental parasites infectivity                 Expression purification poly-His-tagged <br />   host pressure.                                                               recombinant TbRpiB TcRpiB <br />                                                                                   The TbRPIB TcRPIB genes excised pGEM- <br />                                                                                T Easy vector (using NdeI/EcoRI restriction enzyme combina- <br /> PPP, likely meet remarkably high proliferation rate of <br />                                                                                tion), gel purified subcloned pET28a(+) expression vector <br /> these parasites [19], and/or protect variety <br />                                                                                (Novagen). The resulting constructs presented poly-His tag (66 <br /> of reactive oxygen nitrogen species [20,21] context an <br /> in vivo infection.                                                             Histidine residues) N-terminal used transform <br />                                                                                E. coli BL21DE3 cells. Both recombinant proteins expressed <br />    Ribose-5-phosphate isomerase (Rpi) catalyzes inter-conversion <br />                                                                                induction log-phase cultures (500 ml; OD600 = 0.6) with <br /> between ribulose-5-phosphate (Ru5P) ribose 5-phosphate (R5P). <br /> Contrary trypanosomatids, Rpi type B (RpiB),               0.5 mM IPTG (isopropyl-b-D- thiogalactopyranoside) 3 h at <br /> presence structurally unrelated Rpi type A (RpiA) humans               37uC agitation 250 rpm/min. Bacteria harvested by <br /> together adverse <span id='am-163' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-164' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-168' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-169' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-173' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-177' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-181' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-185' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-187' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-196' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-197' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-209' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-212' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-215' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-230' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-232' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-235' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-238' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-239' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-240' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span>phenotype</span> observed rpiA-/rpiB-                    centrifugation (4000 rpm, 40 min, 4uC), resuspended in <br /> <span id='am-241' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-242' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-243' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-244' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-245' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-248' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-249' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-251' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-252' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-253' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-254' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-255' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-256' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-261' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-264' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-265' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-266' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-267' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-268' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-269' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-270' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-271' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-272' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-273' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-274' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-280' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-281' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-282' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-283' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-284' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-287' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-288' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-290' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-291' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-292' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-293' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-294' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-295' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-296' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-297' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-298' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-299' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-300' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-301' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-302' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-304' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-305' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-306' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-307' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-308' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-309' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-310' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-311' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-312' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-313' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-314' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-315' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-316' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-317' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-318' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span>knockout</span> Escherichia coli (E. coli) [22] led suggest RpiB           20 ml buffer A (0.5 M NaCl, 20 mM Tris.HCl, pH 7.6). The <br /> an attractive drug target candidate waits characterization.       sample sonicated, according following conditions: <br />    In study, investigate importance RpiB T. brucei           output 4, duty cycle 50%, 10 cycles 15 s each. Centrifugation <br /> bloodstream form viability infectivity.                                    (4000 rpm, 60 min, 4uC) followed obtain the <br />                                                                                bacterial crude extract. The recombinant enzymes purified in <br />                                                                                step using Ni2+ resin (ProBond) pre-equilibrated buffer A. <br /> Materials Methods                                                          The column washed sequentially 2&#226;&#8364;&#8220;3 ml buffer A, <br /> Ethics statement                                                               20 ml bacterial crude extract, 2 ml buffer A 25 mM <br />   All experiments carried accordance                      imidazole, 2 ml buffer A 30 mM imidazole, 2 ml buffer A <br /> IBMC.INEB Animal Ethics Committees Portuguese                          40 mM imidazole, 2 ml buffer A 40 mM imidazole, 2 ml of <br /> National Authorities Animal Health guidelines, according                buffer A 50 mM imidazole, 10 ml buffer A 100 mM imidazole, <br /> the statements directive 2010/63/EU European                     5 ml buffer A 500 mM imidazole 8 ml buffer B (1 M <br /> Parliament Council. IL, JT ACS                          imidazole, 0.5 M NaCl, 200 mM Tris, pH 7.6). TbRpiB and <br /> accreditation animal research given Portuguese Veteri-                TcRpiB eluted fractions buffer A containing <br /> nary Direction (Ministerial Directive 1005/92).                                100 500 mM imidazole. Dialysis performed <br />                                                                                100 mM Tris/HCl (pH 7.6). <br /> Parasite culture                                                                  <span id='am-6' about='protege:TO' typeof='owl:Thing'>To</span> generate rat polyclonal antibody TbRpiB, rabbit <br />   Procyclic bloodstream T. brucei Lister 427 cultivated               polyclonal antibodies TbRpiB TcRpiB, animal <br /> in MEM-Pros HMI-9 medium, respectively, previously                      immunized 150 mg recombinant protein. After 2 <br /> described [23]. Bloodstream forms containing pHD1313 [24]                 weeks, 4 boosts 100 mg recombinant TbRpiB TcRpiB <br /> maintained 0.2 mg/ml phleomycin.                                          given weekly. The collected blood samples centrifuged <br />                                                                                obtain sera. <br /> Cloning trypanosomes RPIB genes <br />   Ribose 5-phosphate isomerase B genes T. brucei (TbRPIB)                 Protein alignments homology models <br /> and T. cruzi (TcRPIB) obtained performing PCR                         Multiple sequence alignments performed ClustalW [25] <br /> genomic DNA Trypanosama brucei TREU927 Try-                           images prepared Aline, Version 011208 [26]. Homology <br /> panosoma cruzi CL Brener Non-Esmeraldo-like. Fragments                  models obtained SWISS-MODEL, using PDB accession <br /> open reading frames TbRPIB (Tb927.11.8970; chromosome                       <span id='am-5' about='Thesaurus:code' typeof='owl:Thing'>code</span> 3K7S template [27&#226;&#8364;&#8220;29]. 3D structures rendered <br /> Tb927_11_v5 2,462,183 2,463,307) TcRPIB                            PyMOL (The PyMOL Molecular Graphics System, Version <br /> (Tc00.1047053508601.119; chromosome TcChr30-P                             1.3, Schro&#194;&#168;dinger, LLC). <br /> 475,724 476,203) PCR-amplified using Taq DNA <br /> polymerase proofreading activity (Roche). The primers                Enzyme assays <br /> as follows: sense primer 59 - CAATTTCCATATGACGCG-                                TbRpiB activity assessed Km determination for <br /> CAAGGTGGC - 39 antisense primer 59 - CCCAAG-                               R5P Ru5P, 4-deoxy-4-phospho-D-erythronohy- <br /> CAAGCTTCTAACAACCATTCG - 39, sense primer 59 -                                  droxamic acid (4-PEH) (kindly provided Dr. Laurent Salmon) <br /> CAATTTCCATATGACGCGCCGAGTCGC - 39 antisense                                 inhibitory capacity TbRpiB, 4-PEH inhibition <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                        2                          January 2015 | Volume 9 | Issue 1 | e3430 <br />                                                                                               Trypanosoma brucei Ribose 5-Phosphate Isomerase B <br />  <br />  <br /> mechanism characterization. Firstly, determine Km R5P            (Molecular probes, Life technologies) Streptavidin-FITC (BD <br /> and characterize 4-PEH-inhibition mechanism, direct                    Pharmingen) secondary antibodies (1:1000 diluted blocking <br /> spectrophotometric method 290 nm [30] used, quantify              solution) 1 h room temperature humidified <br /> Ru5P formation. Km determination performed R5P                       atmosphere, washed twice PBS. Vertical stacks were <br /> concentrations range 3.1 50 mM Tris/HCl                 captured, using confocal microscope Leica TCS SP5II and <br /> (pH 7.6). For 4-PEH inhibition mechanism characterization,              LAS 2.6 software (Leica Microsystems, Germany). Mean fluores- <br /> experiment performed presence 0.5 mg enzyme                cence intensity aldolase RpiB determined stack <br /> and 0.1, 0.4, 0.7 1 mM inhibitor. All inhibitors tested          projected co-localization areas. Quantifications were <br /> in presence 3.1 mM R5P. A negative control                  carried using ImageJ software (version 1.43u). <br /> using heat inactivated enzyme. The TcRpiB enzyme used as <br /> a positive control [31]. A calibration curve Ru5P, using            Digitonin permeabilization <br /> referred method, established determine enzyme activity.                 For sample condition, bloodstream cells washed once <br /> An absorbance 0.0381 290 nm considered 1 mM                   cold trypanosome homogenisation buffer (THB), composed <br /> Ru5P. To determine Km Ru5P test 4-PEH                        25 mM Tris, 1 mM EDTA 10% sucrose, pH = 7.8. Just <br /> inhibition well, modification Dische&#226;&#8364;&#8482;s Cysteine-Carbazole           cell lyses, leupeptin (final concentration 2 mg/ml) and <br /> method used [32]. To determine Km, incubation mixture                different digitonin quantities (final concentrations 5, 12.5, 25, <br /> contained 5 ml 0.05 mg enzyme buffer A [100 mM Tris/               50, 100, 150 200 ug/ml) added 500 ml cold THB, <br /> HCl (pH 8.4), 1 mM EDTA 0.5 mM 2-mercaptoethanol]                       cell pellet resuspension. Untreated cells (0 mg/ml digitonin) <br /> plus 5 ml Ru5P, giving final concentrations 0.625            completely permeabilized (total release, result of <br /> 10 mM Ru5P, used. For inhibition assay, Ru5P concentra-                 incubation 0.5% Triton X-100) used comparison. Each <br /> tion used 1.25 mM. Incubation 10 min room               sample condition incubated 60 min ice, then <br /> temperature. Following incubation, 15 ml 0.5% cysteinium                 centrifuged 2000 rpm, 4uC, 10 min. Supernatants were <br /> chloride, 125 ml 75% (v/v) sulfuric acid 5 ml 0.1%              taken 500 ml cold THB added pellet. All <br /> solution carbazole ethanol added. After 30 min <br />                                                                             fractions analysed Western blot Rpi (108 cells per <br /> standing room temperature, A546 determined. A blank <br />                                                                             well; 1:1000 polyclonal rabbit anti-TbRpiB primary antibody), <br /> without enzyme run substrate inhibitor <br />                                                                             enolase (107 cells well; 1:5000 polyclonal rabbit anti-enolase as <br /> concentration. Reaction linearity checked varying enzyme <br />                                                                             primary antibody) aldolase (107 cells well; 1:5000 <br /> concentration time. To estimate remaining Ru5P, a <br />                                                                             polyclonal rabbit anti-aldolase primary antibody). HRP- <br /> calibration curve generated. In assay conditions, 1 mM <br />                                                                             conjugated goat anti-rabbit (1:5000) used secondary <br /> of Ru5P gave A546 0.270 final reaction volume of <br />                                                                             antibody. <br /> 155 ml. <br />                                                                             Generation transgenic RNAi cell lines <br /> Immunofluorescence <br />                                                                                TbRPIB fragment (sense oligo BglII &#226;&#8364;&#8220; SphI linker 59 &#226;&#8364;&#8220; <br />    For anti-TbRpiB antibodies validation, cells log-phase <br />                                                                             GAGAAGATCTGCATGCGCGCAAGGTGGCTATCGGTG - <br /> cultures T. brucei RNAi cell lines wt strain centrifuged <br />                                                                             39, antisense oligo ClaI &#226;&#8364;&#8220; SalI 59 &#226;&#8364;&#8220; GCTAGCTA- <br /> and resuspended 106/ml PBS. The cells fixed m- <br />                                                                             CAGCTGACGGTCCTCCCCGCTGTATG &#226;&#8364;&#8220; 39) cloned <br /> Chamber 12 (Ibidi) 15 min, room temperature, PBS <br />                                                                             twice opposite direction sides &#226;&#8364;&#732;&#226;&#8364;&#732;stuffer&#226;&#8364;&#8482;&#226;&#8364;&#8482; the <br /> containing 4% p-formaldehyde, washed twice PBS, then <br />                                                                             pHD1144 vector. The resulting construct obtained through <br /> permeabilized PBS containing 0.1% Triton X-100. The <br />                                                                             HindIII BglII digestion cloned pHD1145. The final <br /> coverslips incubated PBS containing 10% FCS during <br /> 60 min, room temperature, humidified atmosphere                 construct transfect bloodstream forms pHD1313, <br /> washed twice PBS/2% FCS. Then, incubated primary                  stable individual clones selected 7.5 mg/ml of <br /> rat rabbit polyclonal antibodies TbRpiB (1:100               hygromycin. For functional complementation, TcRPIB fragment <br /> 1:1000 respectively, diluted blocking solution) overnight,       (sense oligo HindIII linker 59 - GAAGCTTAT- <br /> 4uC, followed washes PBS/2% FCS (5 min one).               GACGCGCCGAGTCGCAAT - 39, antisense oligo with <br /> Subsequently, cells incubated Alexa Fluor 647                     BglII linker 59 - AGATCTTCATTTTACCCCTTTGTTCC - <br /> conjugated goat anti-rat Alexa Fluor 488 conjugated goat                 39), cloned pHD1034 vector (digested HindIII and <br /> anti-rabbit secondary antibodies (Molecular probes Life                BamHI). After transfection [33], individual clones selected <br /> technologies) (1:500 diluted blocking solution) 1 h room          0.2 mg/ml puromycin. <br /> temperature humidified atmosphere, washed twice with <br /> PBS. The coverslips stained mounted                      In vitro vivo analysis TbRpiB RNAi <br /> Vectashield-DAPI (Vector Laboratories, Inc.). Images                      For vitro growth curves, cell lines seeded 26105 <br /> captured using fluorescence microscope AxioImager Z1                    parasites/ml complete HMI-9 medium, absence and <br /> software Axiovision 4.7 (Carl Zeiss, Germany). Pseudo-coloring              presence 100 ng/ml tetracycline (tet). Every 24 h, day <br /> of images carried using ImageJ software (version 1.43u).           10, cell growth monitored microscopically. For vivo <br /> In case TbRpiB immunolocalization, bloodstream form T.                   infections, 24 h absence selective drugs, a <br /> brucei wt cells probed using primary rat anti-TbRpiB (1:100            48 h tet induction, 104 wt transgenic parasites were <br /> diluted blocking solution) primary rabbit polyclonal                 inoculated intraperitoneally 6&#226;&#8364;&#8220;8 weeks old BALB/c mice <br /> antibody aldolase (glycosome marker, 1:5000 diluted              (n = 3&#226;&#8364;&#8220;8). 48 h prior infection, RNAi induced mice were <br /> blocking solution). Cells incubated biotin                   treated 1 mg/ml doxycycline hyclate 5% sucrose <br /> conjugated goat anti-rat (1:500 diluted blocking solution) (BD           containing water [34], RNAi non-induced mice given <br /> Pharmingen) 1 h room temperature humidified atmo-                  standard water. Parasitaemia measured daily day <br /> sphere, washed twice PBS/2% FCS. Subsequently, cells              post-infection tail blood extraction, period which <br /> were incubated Alexa Fluor 647 conjugated goat anti-rabbit             mice group alive. <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                     3                           January 2015 | Volume 9 | Issue 1 | e3430 <br />                                                                                                Trypanosoma brucei Ribose 5-Phosphate Isomerase B <br />  <br />  <br />  <br /> Northern blot analysis                                                       155 amino acids residues monomer, respectively. Protein <br />    Total RNA isolated &lt;26107 bloodstream forms using                multiple sequence alignment RpiB T. cruzi CL Brener <br /> Trizol reagent (Life Technologies). 10 mg RNA directly                  Esmeraldo-like (Tc00.1047053509199.24; PDB accession <span id='am-475' about='Thesaurus:code' typeof='owl:Thing'>code</span> <br /> separated overnight formaldehyde agarose-gel electrophoresis,             3K7S [36]), T. cruzi CL Brener Non-Esmeraldo-like <br /> transferred nylon membrane capillarity fixed UV             (Tc00.1047053508601.119) T. brucei (Tb927.11.8970) is <br /> irradiation. The membrane prehybridized hybridization               shown S1A Fig. The scale colour, cyan (low-similarity <br /> bottle 56 SSC, 0.5% SDS salmon sperm DNA (200 mg/                    residues) red (high-similarity residues), underlines degree of <br /> ml) 16Denhardt&#226;&#8364;&#8482;s solution 2 hours 65uC. TbRPIB                similarity protein sequences, seen the <br /> signal recognition particle (SRP; Tb927.8.2861_7SL) probes              TcRpiB (Esmeraldo like strain) ribbon representation (S1B Fig.). <br /> generated PCR presence [32P]-labelled dCTP using                The superposition TcRpiB (Esmeraldo like strain) structure <br /> Prime-It RmT random primer labelling kit (Stratagene) followed               (grey) (PDB code 3K7S), homology models generated for <br /> by purification using QIAquick Nucleotide Removal Kit (QIA-                  TcRpiB (Non Esmeraldo like strain) (purple) TbRpiB (blue) <br /> GEN). Denaturated radioactive probes added                       high structural homology strict conservation the <br /> prehybridization solution 65uC incubated overnight. After             residues involved R5P binding pocket (S1A, C Fig.). <br /> rinsing membrane twice 5 min. 26 SSC/0.1% SDS,                     Biochemical studies performed using histidine-tagged <br /> the probes washed washes 30 minutes                  fusion TbRpiB TcRpiB (positive control) proteins expressed <br /> 0.16 SSC/0.1% SDS 65uC membrane exposed                      E. coli purified non-denaturing conditions (Figs. 1A, <br /> Fugifilm FLA-3000 reader screen. ImageJ software (version 1.43u)             S2A). The T. brucei T. cruzi [31] enzymes vitro ribose <br /> was used RNA quantification.                                             5-phosphate isomerase activity, proteins use R5P <br />                                                                              Ru5P substrates. For R5P, T. brucei protein showed a <br /> Protein extracts western blot analysis                                   significantly higher Km (2.8 fold increase, p,0.05), lower <br />    Cell free extracts obtained RIPA buffer (20 mM Tris-              maximum velocity (Vmax) catalytic constant (kcat) compared to <br /> HCl (pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA,                          T. cruzi enzyme (Table 1 S2B Fig.). For Ru5P, Km the <br /> 1% NP-40, 1% sodium deoxycholate, 2.5 mM sodium pyrophos-                    T. brucei protein significantly different T. <br /> phate, 1 mM b-glycerophosphate, 1 mM Na3VO4), freshly-                  cruzi enzyme value, Vmax kcat higher (&lt;1.5 fold, <br /> added complete protease inhibitor cocktail (Roche Applied                    p,0.05) (Table 1 S2B Fig.). Both T. brucei T. <br /> Science). The total protein quantified using Biorad               cruzi enzymes exhibited significant lower Kms Ru5P for <br /> Commercial Kit (Reagents A, B S) samples               R5P, (5.2 fold, p,0.05 3.7 fold, p,0.01, respectively), <br /> kept -80uC. For analysis parasites collected mice,                suggesting reaction occurs preferentially Ru5P R5P. <br /> trypanosomes purified mouse blood using DE-52                    The turnover values (kcat) significantly higher for <br /> (Whatman) column [35].                                                       Ru5P R5P, T. brucei (p = 0.001) T. cruzi (p, <br />    For Western blotting, 10 mg recombinant TbRpiB                     0.001) enzymes (Table 1 S2B Fig.). <br /> TcRpiB proteins resolved 15% SDS/PAGE (Tris-Tricine                     The reaction mechanism ribose 5-phosphate isomerase <br /> gel), 30 mg total soluble cell extract 107 parasites       involves steps: initial opening furanose ring of <br /> resolved 12% Tris-Glycine SDS/PAGE,                     R5P, followed aldolase-ketose isomerisation, cis- <br /> transferred nitrocellulose Hy-bond ECL membrane                      enediolate high energy intermediate [31]. 4-PEH been <br /> (Amersham Biosciences). The membrane blocked 5% (w/                   described act competitive inhibitor compromises <br /> v) non-fat dried skimmed milk PBS/0.1% Tween-20 (blocking                 binding 1,2-cis-enediolate intermediate [37]. The inhibitory <br /> solution), followed incubation anti-His-tag rabbit                capability 4-PEH screened vitro, resulting IC50 of <br /> antibody (MicroMol-413) (1:1000) combination anti-                0.8 mM 0.7 mM TbRpiB (Fig. 1B) TcRpiB (S2C <br /> TbRpiB rabbit antibody (1:1000) anti-aldolase rabbit                 Fig.), respectively, Ki values 2.2 (Fig. 1C) 1.6 mM <br /> antibody (1:5000) blocking solution 4uC overnight, respec-             (S2D Fig.). 4-PEH showed, expected, competitive inhibition <br /> tively. Blots washed PBS/0.1% Tween-20 (3 times                    behaviour, using increasing concentrations inhibitor, a <br /> 15 min). Horseradish peroxidase-conjugated goat anti-rabbit IgG              progressive increase Km R5P Vmax alteration <br /> (Amersham) (1:5000 1 h, room temperature) used             observed (Figs. 1D, S2E). The inhibitor behaviour, also <br /> secondary antibody. The membranes developed using                       IC50 Ki values agreement described <br /> SuperSignal WestPico Chemiluminescent Substrate (Pierce).                    T. cruzi enzyme [31,36]. 4-PEH reported a <br /> ImageJ software (version 1.43u) used protein bands                   potent inhibitor Mycobacterium tuberculosis RpiB [37]. <br /> semi-quantification.                                                            Undoubtedly, TbRpiB isomerase activity uses prefer- <br />                                                                              entially ribulose 5-phosphate substrate. <br /> Statistical analysis <br />    Student&#226;&#8364;&#8482;s t-test Graphpad Prism Software (version 5.0)           TbRpiB expression subcellular localization <br /> used. p values #0.05 considered statistically significant            Rabbit rat polyclonal antibodies generated the <br /> (* p#0.05, ** p#0.01, *** p#0.001).                                          TbRpiB recombinant protein. Antibody specificity validated, <br />                                                                              induction RpiB RNAi resulted decrease the <br /> Results                                                                      fluorescence intensity bloodstreams compared non- <br />                                                                              induced parasites (S3A, B, C Fig.). Similarly significant decrease <br /> TbRpiB biochemical properties                                                RpiB levels extracts TbRpiB RNAi induced parasites is <br />    An open reading frame sequence similarity RpiB                shown Western blot. Rat rabbit antibodies specificity <br /> identified T. brucei (Tb927.11.8970) T. cruzi                 RpiB appreciated Western blot <br /> (Tc00.1047053508601.119) genomes. Protein sequence alignment                 membranes (S3D, E Fig.). Using rabbit polyclonal antibody <br /> using ClustalW [25] revealed 67% identity TbRpiB versus                  parasite extracts, TbRpiB abundant in <br /> TcRpiB, proteins similarity human ribose               procyclic forms bloodstream forms (Fig. 2A). To <br /> 5&#226;&#8364;&#8220;phosphate isomerase A. TcRpiB TbRpiB contain 159                   ascertain RpiB subcellular localization bloodstream forms, <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                      4                           January 2015 | Volume 9 | Issue 1 | e3430 <br />                                                                                                     Trypanosoma brucei Ribose 5-Phosphate Isomerase B <br />  <br />  <br />  <br />  <br /> Fig. 1. Biochemical properties TbRpiB expressed E. coli. (A) 10 mg TbRpiB recombinant protein analyzed SDS-PAGE Coomassie <br /> blue staining. Mw, molecular weight marker. Western blot analysis his-tagged recombinant protein probed rabbit anti-histidine monoclonal <br /> antibody (MicroMol-413) (1:1000). (B) Inhibition (%) TbRpiB activity 4PEH. (C) Plot Kmapp/Vmax versus 4PEH concentrations; Ki corresponds to <br /> the symmetric value X-axis intersection. (D) Plots showing effect different 4PEH concentrations inverse initial velocity versus <br /> the inverse concentrations R5P. (B&#226;&#8364;&#8220;D) The values correspond means 6 standard deviation replicates, data is <br /> representative independent experiments. <br /> doi:10.1371/journal.pntd.0003430.g001 <br />  <br />  <br /> two complementary approaches, immunofluorescence digito-                    marker, enolase (almost supernatant 25 mg/ml <br /> nin fractionation, performed. Fluorescent confocal micros-                 digitonin), practically released 100 mg/ml digitonin <br /> copy analysis suggests TbRpiB despite localized mainly               (Fig. 2C). In conclusion, RpiB localizes mainly cytosol of <br /> in cytosol glycosomes                           bloodstream forms. <br /> colocalization glycosomal marker, aldolase [38] (Fig. 2B). <br /> Upon digitonin fractionation, RpiB showed intermediate                       In vitro vivo analysis TbRpiB RNAi <br /> <span id='am-476' about='xsp:pattern' typeof='owl:Thing'>pattern</span> glycosomal marker, aldolase (still partially               To assess TbRpiB targeting affects vitro bloodstream forms <br /> the pellet 200 mg/ml digitonin treatment) cytosolic               growth, RNAi RpiB induced. This resulted lower <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                         5                              January 2015 | Volume 9 | Issue 1 | e3430 <br />                                                                                                     Trypanosoma brucei Ribose 5-Phosphate Isomerase B <br />  <br />  <br />  <br />  Table 1. TbRpiB kinetic parameters. <br />  <br />  <br />                                                                  R5P Ru5P                                 Ru5P R5P <br />  <br />  Km (mM)                                                         12.5064.43                                  2.3960.94 <br />  Vmax 61023(mM.s21)                                              1.1760.16                                   5.8460.79 <br />  kcat (s21)                                                      12.0061.58                                  39.4465.32 <br />  kcat/Km (M21.s21)                                               9.606102                                    1.646104 <br />  <br />  The values means 6 standard deviation obtained 3 independent experiments. <br />  doi:10.1371/journal.pntd.0003430.t001 <br />  <br />  <br /> mRNA protein levels 1 2 days post-induction (Fig. 3A                      Discussion <br /> and B, respectively). Using ImageJ software estimate decrease <br /> of approximately 93% protein levels 48 h RNAi post-                            In study demonstrated TbRpiB, like related <br /> induction. The growth TbRpiB RNAi tet(-) wt tet(-) cell                    TcRpiB Leishmania donovani RpiB (LdRpiB) enzymes, in <br /> lines shown similar (Fig. 3C). A significant decrease             vitro ribose 5-phosphate isomerase activity [31,43]. Based the <br /> vitro cell proliferation induced versus non-induced RNAi cell                  theoretical homology model, TbRpiB predicted dimeric. <br /> lines seen day 4 cumulative growth curve                    Although dimer comprises complete functional <span id='am-2' about='Thesaurus:Unit' typeof='owl:Thing'>unit</span>, <br /> (Fig. 3C).                                                                        tetramers observed available RpiB structures except <br />    To test importance RpiB parasite infectivity                   Mycobacterium tuberculosis RpiB [36]. Similarly T. <br /> disease model, groups BALB/c mice inoculated                     cruzi, Clostridium thermocellum Pisum sativum Rpi enzymes, <br /> the wt parental cell line groups RNAi cell                 TbRpiB ability using R5P Ru5P substrates, <br /> line. Some mice fed water containing doxycycline (Dox)                  remarkable preference Ru5P [31,44,45]. However, <br /> to induce downregulation TbRpiB, whilst remaining mice                     differences affinity pronounced trypanosomes <br /> were kept non-induced controls. A Western blot confirmed                   enzymes. Indeed, differences higher TbRpiB <br /> reduction protein level 48 h RNAi induced parasites used                compared TcRpiB. Analysis enzymes from <br /> for mice infections (Fig. 4A). Blood samples taken                  trypanosomatids (TcRpiB, LdRpiB TbRpiB) shows that <br /> mice daily intervals chart parasitaemia (Fig. 4B). Animals                  TbRpiB LdRpiB highest Km kcat value for <br /> achieving parasitaemia greater 108 trypanosomes                        R5P substrate, respectively [31,43]. Nevertheless, speculate <br /> millilitre euthanized. In vivo growth TbRpiB RNAi                     differences result fact parasite <br /> Dox(-) trypanosomes significantly different wt               enzymes expressed purified recombinant proteins in <br /> Dox(-) parasites. However significant decrease parasitae-                bacteria purified directly trypanosomes extracts. <br /> mia induced versus non-induced RNAi cell lines seen.                       Consequently, differences protein post-transcriptional process- <br /> Within 6 days inoculation, contrary mice infected                      ing and/or changes protein conformation excluded. <br /> induced RNAi cell line (in overall parasitaemias remained                      RpiB expressed T. brucei procyclic bloodstream <br /> below detection limit, 56104 trypanosomes/ml), mice infected                  forms, data indicate higher expression procyclics. <br /> with control parasites developed high levels parasitaemia. As                Interestingly, previous study shown higher levels TbRPIB <br /> consequence, contrast mice infected wt TbRpiB                  mRNA (Tb927.11.8970) logarithmic phase procyclic forms <br /> RNAi Dox(-) parasites, culled sooner (between eighth                   compared bloodstream forms [46]. However, biological <br /> to thirteenth day post-infection), TbRpiB RNAi Dox(+)                        meaning, any, remains elucidated. <br /> euthanized eighteenth day post-infection (Fig. 4C).                         Regarding RpiB subcellular localization bloodstream forms, <br /> Eventually parasitaemia increased TbRpiB RNAi                         protein despite mainly cytosol present in <br /> Dox(+) mice, emergence &#226;&#8364;&#732;&#226;&#8364;&#732;RNAi revertants&#226;&#8364;&#8482;&#226;&#8364;&#8482; (Fig. 4D)                glycosomes. This explain previous proteomic analysis <br /> [39&#226;&#8364;&#8220;42]. In way, ribose 5-phosphate isomerase B despite                failed TbRpiB enzyme purified glycosomes [47]. The <br /> dispensable vitro, confers optimal vitro growth highly               glycosomal localization observed dual-localization can <br /> relevant mice infections.                                                     justified presence peroxisomal targeting signal, <br />                                                                                   PTS2 (-KVAIGADHI-), N-terminus [48]. Moreover, other <br />                                                                                   enzymes hexose-monophosphate pathway, present <br /> Complementation TbRpiB RNAi phenotype                                          glycosomes, mainly cytosol (e.g. <br />    Functional complementation T. brucei RNAi cell lines                   glucose-6-phosphate dehydrogenase, 6-phosphogluconolactonase <br /> the T. cruzi homologue performed, TcRpiB vitro                   transketolase) [49,50]. <br /> isomerase activity TcRPIB nucleotide sequence sufficiently                    TbRpiB clearly needed optimal vitro parasite growth, <br /> different avoid TbRpiB RNAi. Western blot analysis confirmed                   know essential survival since <br /> TbRpiB downregulation induced RNAi parasites,                         protein remained RNAi. Nevertheless, results show <br /> TcRpiB expression exclusively complemented parasites                           TbRpiB important parasites infectivity vivo, through <br /> (Fig. 5A). Cells RNAi complemented TcRpiB grew                      appearance RNAi revertants reversion phenotype <br /> equally vitro (Fig. 5B), virulent vivo                   complemented parasites. Infectivity defects bloodstreams with <br /> (Fig. 5C, D), wild-type. RNAi revertants appeared                   reduced levels TbRpiB shown monomorphic T. <br /> the course infection induced TbRpiB RNAi infected mice,                     brucei strain. This strain abnormally virulent typically mice <br /> but induced complemented TbRpiB RNAi infected mice                         survive longer &lt;10 days. In future, be <br /> (Fig. 5E). As result, complementation restored vitro                  interesting test role RpiB chronic infection, as <br /> vivo phenotypes.                                                                  caused pleomorphic strains. Interfering PPP <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                           6                           January 2015 | Volume 9 | Issue 1 | e3430 <br />                                                                                                   Trypanosoma brucei Ribose 5-Phosphate Isomerase B <br />  <br />  <br />  <br />  <br /> Fig. 2. TbRpiB expression life cycle stages localization bloodstream forms. (A) RpiB expression T. brucei life-cycle stages; <br /> 30 mg protein bloodstream (BS) procyclic (PC) total lysates analysed Western blot probed rabbit anti-TbRpiB (1:1000) and <br /> anti-aldolase (loading control; 1:5000) polyclonal antibodies. Data representative independent experiments. (B) Immunofluorescence <br /> analysis confocal microscopy bloodstream forms TbRpiB. Nuclear kinetoplast DNA labelled DAPI staining (blue). RpiB (green) and <br /> aldolase (red) labelled respectively rat anti-TbRpiB (1:100) rabbit anti-aldolase (1:5000) antibodies. White arrowheads indicate RpiB and <br /> aldolase co-localization areas magnified right panels. Mean fluorescence intensity (MFI) aldolase (red) RpiB (green) co- <br /> localization areas (white dotted circle) determine stack. Images maximal Z-projections 50 33 contiguous stacks separated by <br /> 0.1 mm. Scale Bars: 2.5 (top left panel), 5 (below left panel), 0.5 (top right panel) 1 mm (below right panel). (C) Supernatant (S) pellet (P) <br /> fractions obtained different concentrations digitonin subjected Western blot analysis probed rabbit antibodies against <br /> TbRpiB (1:1000), enolase (cytoplasmic marker; 1:5000), aldolase (glycosome marker; 1:5000). Data representative independent <br /> experiments. Untreated cells completely permeabilized incubation 0.5% Triton X-100 [total release (TR)] used controls. <br /> doi:10.1371/journal.pntd.0003430.g002 <br />  <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                        7                             January 2015 | Volume 9 | Issue 1 | e3430 <br />                                                                                                 Trypanosoma brucei Ribose 5-Phosphate Isomerase B <br />  <br />  <br />  <br />  <br /> Fig. 3. In vitro effect RNAi-mediated RpiB downregulation T. brucei bloodstream forms. (A) Northern (B) Western blot analysis of <br /> mRNA protein levels, respectively, RpiB RNAi. SRP aldolase used loading controls, respectively. Rabbit anti-TbRpiB (1:1000) anti- <br /> aldolase (1:5000) polyclonal antibodies used primary antibodies. (C) Growth curve wt versus representative RpiB RNAi cell line. Black <br /> squares blue diamonds represent wt growth absence presence tetracycline (tet) green triangles red circles represent RpiB <br /> RNAi clone growth absence presence tet, respectively. Cumulative cell numbers (product cell number total dilution) plotted. <br /> Values represent averages independent experiments using representative RpiB RNAi clone error bars indicate standard deviation. <br /> Statistical differences non-induced induced TbRpiB RNAi clone depicted (* p#0.05, ** p#0.01). <br /> doi:10.1371/journal.pntd.0003430.g003 <br />  <br />  <br />  <br />  <br /> Fig. 4. In vivo effect RNAi-mediated RpiB downregulation T. brucei bloodstream forms. (A) Western blot analysis Rpi protein levels <br /> in bloodstream forms 48 h tet induction, used mice infections. (B) Groups mice (n = 3&#226;&#8364;&#8220;7) infected intraperitoneally with <br /> 104 control wt (black squares blue diamonds) representative RNAi clone (green triangles red circles). The mice untreated <br /> (black squares green triangles) treated 1 mg/ml Dox (blue diamonds red circles) water supply. Parasitaemias group are <br /> shown period time mice death. Values means errors bars indicate + standard deviation. 56104 trypanosomes/ <br /> ml blood detection limit. Mice culled parasitaemia reached 108 cells/ml. (C) Kaplan&#226;&#8364;&#8220;Meier survival analysis mice infected with <br /> non-induced induced wt cell line (black blue line, respectively) versus non-induced induced representative RNAi clone (green red <br /> line, respectively). Parasitaemias survival curve representative independent experiments using different RNAi clones. (D) Western <br /> blot analysis RpiB levels representative non-induced Dox-induced RNAi clone collected mice euthanized confirmed the <br /> appearance RNAi revertants. Statistical differences non-induced induced TbRpiB RNAi clone depicted (** p#0.01). <br /> doi:10.1371/journal.pntd.0003430.g004 <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                      8                             January 2015 | Volume 9 | Issue 1 | e3430 <br />                                                                                                   Trypanosoma brucei Ribose 5-Phosphate Isomerase B <br />  <br />  <br />  <br />  <br /> Fig. 5. Rescue RpiB RNAi mediated defect expression TcRpiB. (A) Western blot analysis TbRpiB TcRpiB levels bloodstream <br /> forms 48 h tetracycline (tet) induction reveal decrease RpiB non-complemented complemented TbRpiB RNAi cells, contrary wt <br /> controls. Parasite extracts probed sequentially, rabbit anti-TbRpiB (1:1000) anti-aldolase (loading control; 1:5000), anti-TcRpiB <br /> (1:1000) primary antibodies. (B) In vitro cumulative growth induced non-complemented complemented wt bloodstream forms (blue diamond <br /> and grey triangle, respectively) versus induced non-complemented complemented representative TbRpiB RNAi clone (red circle and <br /> orange cross, respectively). Values represent average parasite numbers 6 standard deviation independent experiments a <br /> representative RNAi clone. (C) Groups mice (n = 6&#226;&#8364;&#8220;8) infected intraperitoneally 16104 RNAi induced non-complemented and <br /> complemented wt parental cell line (blue diamond grey triangle, respectively) versus non-complemented complemented <br /> representative TbRpiB RNAi clone (red circle orange cross, respectively). Mice treated 1 mg/ml Dox water supply. Mice were <br /> culled parasitaemia reached 108 cells/ml. The mean value parasitaemias group mice + standard deviation shown. (D) <br /> Kaplan&#226;&#8364;&#8220;Meier survival analysis mice infected Dox induced non-complemented complemented wt cell line (blue grey lines, <br /> respectively) versus induced non-complemented complemented representative TbRpiB RNAi clone (red orange lines, respectively). Data are <br /> representative independent experiments different RNAi clones. (E) Western blot analysis RpiB levels representative non- <br /> complemented complemented TbRpiB RNAi clone isolated mice blood euthanized, showing emergence RNAi <br /> revertants induced non-complemented RNAi clones. Statistical differences non-complemented complemented induced TbRpiB <br /> RNAi clone depicted (* p#0.05, ** p#0.01). <br /> doi:10.1371/journal.pntd.0003430.g005 <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                        9                             January 2015 | Volume 9 | Issue 1 | e3430 <br />                                                                                                        Trypanosoma brucei Ribose 5-Phosphate Isomerase B <br />  <br />  <br /> non-oxidative branch showed detrimental host                           3K7S) (grey) TcRpiB (Tc00.1047053508601.119) (purple) <br /> pressure, highly proliferative parasitic forms,                 TbRpiB (Tb927.11.8970) (blue) homology models. Ligand <br /> be defective production ribose 5-phosphate                     color scheme: R5P shown yellow (oxygen, pink; phosphorous <br /> nucleotide nucleic acid synthesis. Moreover, enzyme                    orange). <br /> capable producing ribose 5-phosphate, ribokinase, essential                  (TIF) <br /> for parasites survival attempts remove alleles were <br />                                                                                    S2 Fig.      Biochemical properties TcRpiB (Tc00. <br /> unsuccessful [51]. <br />                                                                                    1047053508601.119) expressed E. coli. (A) 10 mg of <br />    TbRpiB protein reported dispensable under <br /> standard laboratory culture conditions crucial parasites                   TcRpiB recombinant protein analyzed SDS-PAGE and <br /> growth animal host [52,53]. In rich culture conditions,                     Coomassie blue staining. Mw, molecular weight marker. Western <br /> parasites uptake essential nutrients extracellular                    blot analysis his-tagged recombinant protein probed rabbit <br /> medium, available blood. Moreover,                       anti-histidine monoclonal antibody (MicroMol-413) (1:1000). (B) <br /> vivo, parasites need deal pressure host immune                    Kinetic parameters direct (R5P Ru5P) inverse (Ru5P to <br /> response.                                                                          R5P) reaction. The values means 6 standard deviation <br />    As proteins [54,55], vitro results differ             obtained 3 independent experiments. (C) Inhibition (%) of <br /> ones achieved <span id='am-397' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-398' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-399' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-400' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-401' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-402' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-403' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-404' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-405' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-406' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-407' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-408' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-409' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-410' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-411' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-412' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-413' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-414' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-415' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-416' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-417' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-418' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-419' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-420' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-421' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-422' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-423' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-424' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-425' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-426' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-427' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-428' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-429' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-430' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-431' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-432' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-433' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-434' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-435' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-436' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-437' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-438' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-439' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-440' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-441' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-442' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-443' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-444' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-445' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-446' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-447' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-448' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-449' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-450' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-451' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-452' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-453' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-454' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-455' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-456' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-457' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-458' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-459' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-460' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-461' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-462' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-463' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-464' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-465' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-466' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-467' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-468' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-469' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-470' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-471' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-472' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-473' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-474' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span>RNA interference</span> target sequencing (RITseq)                       TcRpiB activity 4PEH. (D) Plot Kmapp/Vmax versus 4PEH <br /> screen [56]. Indeed, proteins described significantly                        concentrations; Ki corresponds symmetric value X- <br /> important parasites fitness Alsford colleagues [56]                     axis intersection. (E) Plot showing effect different 4PEH <br /> were studies [54,55]. Despite large-scale RNAi                       concentrations inverse initial velocity versus the <br /> screens proved useful, caution taken                 inverse concentrations R5P. (C&#226;&#8364;&#8220;E) The values <br /> some level false negatives positives, inherent high-                     correspond means 6 standard deviation replicates, <br /> throughput approaches importantly off-target                       data representative independent experiments. <br /> effects [57]. Furthermore, variations different large-scale                (TIF) <br /> RNAi screenings reported explained                    S3 Fig. Validation antibodies TbRpiB. Immu- <br /> use different T. brucei strains, RNAi constructs methods                nofluorescence analysis T. brucei wt representative Rpi <br /> assessing cell growth highlighting importance using                         RNAi clone presence absence tetracycline (tet). RNAi <br /> complementary approaches studies [58]. Despite all,                   induced uninduced cells grown 48 h, fixed and <br /> studies agreement role TbRpiB parasites                   probed rat polyclonal anti-TbRpiB (A) rabbit polyclonal <br /> growth.                                                                            anti-TbRpiB (B) antibody co-stained DAPI. Bars, 5 mm. <br />    To investigate bloodstream forms deleted RpiB                 (C) Quantification TbRpiB fluorescence levels induced cells <br /> completely cleared mice, studies <span id='am-319' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-320' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-321' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-322' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-323' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-324' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-325' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-326' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-327' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-328' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-329' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-330' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-331' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-332' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-333' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-334' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-335' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-336' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-337' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-338' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-339' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-340' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-341' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-342' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-343' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-344' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-345' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-346' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-347' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-348' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-349' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-350' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-351' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-352' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-353' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-354' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-355' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-356' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-357' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-358' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-359' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-360' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-361' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-362' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-363' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-364' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-365' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-366' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-367' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-368' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-369' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-370' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-371' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-372' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-373' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-374' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-375' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-376' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-377' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-378' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-379' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-380' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-381' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-382' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-383' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-384' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-385' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-386' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-387' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-388' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-389' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-390' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-391' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-392' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-393' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-394' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-395' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-396' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span>gene knockout</span> parasites                   [Rpi RNAi tet(+), n = 30] uninduced cells [Rpi RNAi tet(2), <br /> should done.                                                                    n = 30], using rat rabbit polyclonal anti-TbRpiB <br />    Overall results clearly role RpiB bloodstream                 antibodies. Data representative independent experiments <br /> in vitro optimal growth importantly vivo infectivity,                  using different clones. ImageJ software (version 1.43u) was <br /> but suggest conserved role different Trypanosoma                      used fluorescence quantification. p value calculated by <br /> species. In conclusion TbRpiB emerges new potential                           Student&#226;&#8364;&#8482;s t test (*** p#0.001, p,0.001). (D, E) Whole <br /> therapeutic target African sleeping sickness.                              membrane resulting Western blot analysis RpiB levels, in <br />                                                                                    T. brucei wt representative Rpi RNAi clone, presence <br /> Supporting Information                                                             absence tet. The membrane probed rat anti- <br />                                                                                    TbRpiB (1:100) (D) rabbit anti-TbRpiB (1:1000) (E), after <br /> S1 Fig.   Sequence alignment ribbon representation <br />                                                                                    membrane stripping, rabbit anti-aldolase (1:5000) loading <br /> of RpiB protein trypanosomes. (A) ClustalW align- <br />                                                                                    control. <br /> ment RpiB T. cruzi CL Brener Esmeraldo-like <br /> (Tc00.1047053509199.24; PDB accession code 3K7S), T. cruzi                         (TIF) <br /> CL Brener Non-Esmeraldo-like (Tc00.1047053508601.119) and <br /> T. brucei (Tb927.11.8970). The residues colored according                   Acknowledgments <br /> ALSCRIPT Calcons (Aline version 011208) using predefined                         We like thank Dr. Paul Michels Universite&#194;&#180; catholique de <br /> colour scheme (red: identical residues; orange blue: scale                   Louvain, Belgium, sending enolase antibody Dr. Laurent <br /> conservation amino acid properties; white: dissimilar residues).                Salmon Laboratoire Chimie Universite Paris-Sud XI, France <br /> Secondary structure TcRpiB crystallographic model (PDB code                     providing 4-deoxy-4-phospho-D-erythronohydroxamic acid (4-PEH) <br /> 3K7S) (grey) theoretical homology models TcRpiB                            inhibitor. We thank Claudia Helbig assistance Heidelberg. <br /> (Tc00.1047053508601.119) (purple) TbRpiB (Tb927. <br /> 11.8970) (blue) depicted alignment. Black circles                    Author Contributions <br /> indicate R5P binding residues. (B) Ribbon representation                        Conceived designed experiments: IL JF JT ACdS. Performed the <br /> TcRpiB Esmeraldo-like (PDB code 3K7S) colored according                     experiments: IL JF JT. Analyzed data: IL JF SMR CC JT ACdS NS. <br /> sequence similarity TcRpiB Non-Esmeraldo-like TbRpiB                      Contributed reagents/materials/analysis tools: CC SMR NR NS. Wrote <br /> as shown (A). (C) Superposition TcRpiB structure (PDB code                   paper: IL JF CC SMR JT ACdS. <br />  <br /> References <br />  1. MacGregor P, Szoor B, Savill NJ, Matthews KR (2012) Trypanosomal immune            anti-parasite antibody responses abolishment vaccine-induced memory <br />     evasion, chronicity transmission: elegant balancing act. Nat Rev            responses. PLoS Pathog 4: e1000078. <br />     Microbiol 10: 431&#226;&#8364;&#8220;438.                                                          3. Lejon V, Mumba Ngoyi D, Kestens L, Boel L, Barbe B, et al. (2014) Gambiense <br />  2. Radwanska M, Guirnalda P, De Trez C, Ryffel B, Black S, et al. (2008)              human african trypanosomiasis immunological memory: effect phenotypic <br />     Trypanosomiasis-induced B cell apoptosis results loss protective             lymphocyte profiles humoral immunity. PLoS Pathog 10: e1003947. <br />  <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                           10                               January 2015 | Volume 9 | Issue 1 | e3430 <br />                                                                                                                     Trypanosoma brucei Ribose 5-Phosphate Isomerase B <br />  <br />  <br />  4. Clayton CE, Michels P (1996) Metabolic compartmentation African                        31. Stern AL, Burgos E, Salmon L, Cazzulo JJ (2007) Ribose 5-phosphate isomerase <br />     trypanosomes. Parasitol Today 12: 465&#226;&#8364;&#8220;471.                                                    type B Trypanosoma cruzi: kinetic properties site-directed mutagenesis <br />  5. Hellemond JJ, Bakker BM, Tielens AG (2005) Energy metabolism                          reveal information reaction mechanism. Biochem J 401: 279&#226;&#8364;&#8220;285. <br />     compartmentation Trypanosoma brucei. Adv Microb Physiol 50: 199&#226;&#8364;&#8220;226.                   32. Domagk GF, Alexander WR, Doering KM (1974) Protein structure and <br />  6. Albert MA, Haanstra JR, Hannaert V, Van Roy J, Opperdoes FR, et al. (2005)                    enzymatic activity, XIV. Purification properties ribosephosphate <br />     Experimental silico analyses glycolytic flux control bloodstream form            isomerase skeletal muscle. Hoppe Seylers Z Physiol Chem 355: 781&#226;&#8364;&#8220;786. <br />     Trypanosoma brucei. J Biol Chem 280: 28306&#226;&#8364;&#8220;28315.                                         33. Burkard G, Fragoso CM, Roditi I (2007) Highly efficient stable transformation <br />  7. Chambers JW, Fowler ML, Morris MT, Morris JC (2008) The anti-                                 bloodstream forms Trypanosoma brucei. Mol Biochem Parasitol 153: 220&#226;&#8364;&#8220; <br />     trypanosomal agent lonidamine inhibits Trypanosoma brucei hexokinase 1.                       223. <br />     Mol Biochem Parasitol 158: 202&#226;&#8364;&#8220;207.                                                       34. Rothberg KG, Burdette DL, Pfannstiel J, Jetton N, Singh R, et al. (2006) The <br />  8. Willson M, Sanejouand YH, Perie J, Hannaert V, Opperdoes F (2002)                             RACK1 homologue Trypanosoma brucei required onset and <br />     Sequencing, modeling, selective inhibition Trypanosoma brucei                          progression cytokinesis. J Biol Chem 281: 9781&#226;&#8364;&#8220;9790. <br />     hexokinase. Chem Biol 9: 839&#226;&#8364;&#8220;847.                                                         35. Lanham SM (1968) Separation trypanosomes blood infected rats <br />  9. Chudzik DM, Michels PA, Walque S, Hol WG (2000) Structures type 2                       mice anion-exchangers. Nature 218: 1273&#226;&#8364;&#8220;1274. <br />     peroxisomal targeting signals trypanosomatid aldolases. J Mol Biol 300:            36. Stern AL, Naworyta A, Cazzulo JJ, Mowbray SL (2011) Structures type B <br />     697&#226;&#8364;&#8220;707.                                                                                      ribose 5-phosphate isomerase Trypanosoma cruzi shed light the <br /> 10. Azema L, Lherbet C, Baudoin C, Blonski C (2006) Cell permeation                          determinants sugar specificity structural family. FEBS J 278: 793&#226;&#8364;&#8220;808. <br />     Trypanosoma brucei aldolase inhibitor: evaluation different enzyme-labile              37. Roos AK, Burgos E, Ericsson DJ, Salmon L, Mowbray SL (2005) Competitive <br />     phosphate protecting groups. Bioorg Med Chem Lett 16: 3440&#226;&#8364;&#8220;3443.                              inhibitors Mycobacterium tuberculosis ribose-5-phosphate isomerase B reveal <br /> 11. Caceres AJ, Michels PA, Hannaert V (2010) Genetic validation aldolase                  new information reaction mechanism. J Biol Chem 280: 6416&#226;&#8364;&#8220;6422. <br />     glyceraldehyde-3-phosphate dehydrogenase drug targets Trypanosoma                   38. Clayton CE (1987) Import fructose bisphosphate aldolase glycosomes <br />     brucei. Mol Biochem Parasitol 169: 50&#226;&#8364;&#8220;54.                                                     Trypanosoma brucei. J Cell Biol 105: 2649&#226;&#8364;&#8220;2654. <br /> 12. Helfert S, Estevez AM, Bakker B, Michels P, Clayton C (2001) Roles                     39. Chen Y, Hung CH, Burderer T, Lee GS (2003) Development RNA <br />     triosephosphate isomerase aerobic metabolism Trypanosoma brucei.                       interference revertants Trypanosoma brucei cell lines generated double <br />     Biochem J 357: 117&#226;&#8364;&#8220;125.                                                                       stranded RNA expression construct driven opposing promoters. Mol <br /> 13. Aronov AM, Suresh S, Buckner FS, Van Voorhis WC, Verlinde CL, et al. (1999)                   Biochem Parasitol 126: 275&#226;&#8364;&#8220;279. <br />     Structure-based design submicromolar, biologically active inhibitors                40. Lecordier L, Walgraffe D, Devaux S, Poelvoorde P, Pays E, et al. (2005) <br />     trypanosomatid glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad                       Trypanosoma brucei RNA interference mammalian host. Mol Biochem <br />     Sci U S A 96: 4273&#226;&#8364;&#8220;4278.                                                                      Parasitol 140: 127&#226;&#8364;&#8220;131. <br /> 14. Subramaniam C, Veazey P, Redmond S, Hayes-Sinclair J, Chambers E, et al.                  41. Jetton N, Rothberg KG, Hubbard JG, Wise J, Li Y, et al. (2009) The cell cycle as <br />     (2006) Chromosome-wide analysis gene function RNA interference                   therapeutic target Trypanosoma brucei: Hesperadin inhibits Aurora <br />     african trypanosome. Eukaryot Cell 5: 1539&#226;&#8364;&#8220;1549.                                              kinase-1 blocks mitotic progression bloodstream forms. Mol Microbiol 72: <br /> 15. Bressi JC, Choe J, Hough MT, Buckner FS, Van Voorhis WC, et al. (2000)                        442&#226;&#8364;&#8220;458. <br />     Adenosine analogues inhibitors Trypanosoma brucei phosphoglycerate                  42. Loureiro I, Faria J, Clayton C, Ribeiro SM, Roy N, et al. (2013) Knockdown of <br />     kinase: elucidation novel binding mode 2-amino-N(6)-substituted                    asparagine synthetase A renders Trypanosoma brucei auxotrophic aspara- <br />     adenosine. J Med Chem 43: 4135&#226;&#8364;&#8220;4150.                                                          gine. PLoS Negl Trop Dis 7: e2578. <br />                                                                                               43. Kaur PK, Dinesh N, Soumya N, Babu NK, Singh S (2012) Identification and <br /> 16. Cordeiro AT, Thiemann OH, Michels PA (2009) Inhibition Trypanosoma <br />                                                                                                   characterization novel Ribose 5-phosphate isomerase B Leishmania <br />     brucei glucose-6-phosphate dehydrogenase human steroids effects <br />                                                                                                   donovani. Biochem Biophys Res Commun 421: 51&#226;&#8364;&#8220;56. <br />     viability cultured parasites. Bioorg Med Chem 17: 2483&#226;&#8364;&#8220;2489. <br />                                                                                               44. Yoon RY, Yeom SJ, Kim HJ, Oh DK (2009) Novel substrates ribose-5- <br /> 17. Dardonville C, Rinaldi E, Barrett MP, Brun R, Gilbert IH, et al. (2004) Selective <br />                                                                                                   phosphate isomerase Clostridium thermocellum. J Biotechnol 139: 26&#226;&#8364;&#8220;32. <br />     inhibition Trypanosoma brucei 6-phosphogluconate dehydrogenase high- <br />                                                                                               45. Skrukrud CL, Gordon IM, Dorwin S, Yuan XH, Johansson G, et al. (1991) <br />     energy intermediate transition-state analogues. J Med Chem 47: 3427&#226;&#8364;&#8220; <br />                                                                                                   Purification characterization pea chloroplastic phosphoriboisomerase. <br />     3437. <br />                                                                                                   Plant Physiol 97: 730&#226;&#8364;&#8220;735. <br /> 18. Cronin CN, Nolan DP, Voorheis HP (1989) The enzymes classical <br />                                                                                               46. Jensen BC, Sivam D, Kifer CT, Myler PJ, Parsons M (2009) Widespread <br />     pentose phosphate pathway display differential activities procyclic and <br />                                                                                                   variation transcript abundance developmental stages of <br />     bloodstream forms Trypanosoma brucei. FEBS Lett 244: 26&#226;&#8364;&#8220;30. <br />                                                                                                   Trypanosoma brucei. BMC Genomics 10: 482. <br /> 19. Comini MA OC, Cazzulo JJ (2013) Drug Targets Trypanosomal                          47. Colasante C, Ellis M, Ruppert T, Voncken F (2006) Comparative proteomics of <br />     Leishmanial Pentose Phosphate Pathway. In: Ja&#194;&#168;ger T KO, Flohe&#194;&#180; L, editor.                     glycosomes bloodstream form procyclic culture form Trypanosoma <br />     Trypanosomatid Diseases: Molecular Routes Drug Discovery. Wiley-VCH                        brucei brucei. Proteomics 6: 3275&#226;&#8364;&#8220;3293. <br />     Verlag GmbH &amp; Co. KGaA, Weinheim, Germany. pp. 297&#226;&#8364;&#8220;313.                                   48. Opperdoes FR, Szikora JP (2006) In silico prediction glycosomal enzymes <br /> 20. Husain A, Sato D, Jeelani G, Soga T, Nozaki T (2012) Dramatic increase                     Leishmania major trypanosomes. Mol Biochem Parasitol 147: 193&#226;&#8364;&#8220;206. <br />     glycerol biosynthesis oxidative stress anaerobic protozoan parasite           49. Stoffel SA, Alibu VP, Hubert J, Ebikeme C, Portais JC, et al. (2011) <br />     Entamoeba histolytica. PLoS Negl Trop Dis 6: e1831.                                           Transketolase Trypanosoma brucei. Mol Biochem Parasitol 179: 1&#226;&#8364;&#8220;7. <br /> 21. Ralser M, Wamelink MM, Kowald A, Gerisch B, Heeren G, et al. (2007)                       50. Duffieux F, Van Roy J, Michels PA, Opperdoes FR (2000) Molecular <br />     Dynamic rerouting carbohydrate flux key counteracting oxidative                  characterization enzymes pentose-phosphate pathway of <br />     stress. J Biol 6: 10.                                                                         Trypanosoma brucei. Glucose-6-phosphate dehydrogenase 6-phosphoglu- <br /> 22. Sorensen KI, Hove-Jensen B (1996) Ribose catabolism Escherichia coli:                      conolactonase. J Biol Chem 275: 27559&#226;&#8364;&#8220;27565. <br />     characterization rpiB gene encoding ribose phosphate isomerase B            51. Kerkhoven EJ, Achcar F, Alibu VP, Burchmore RJ, Gilbert IH, et al. (2013) <br />     rpiR gene, involved regulation rpiB expression. J Bacteriol                Handling uncertainty dynamic models: pentose phosphate pathway in <br />     178: 1003&#226;&#8364;&#8220;1011.                                                                               Trypanosoma brucei. PLoS Comput Biol 9: e1003371. <br /> 23. Schlecker T, Schmidt A, Dirdjaja N, Voncken F, Clayton C, et al. (2005)                   52. Ong HB, Sienkiewicz N, Wyllie S, Patterson S, Fairlamb AH (2013) <br />     Substrate specificity, localization, essential role glutathione                    Trypanosoma brucei (UMP synthase <span id='am-85' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-86' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-87' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-95' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-108' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-115' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-124' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-128' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-135' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-142' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-149' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-160' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-161' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span>null mutants</span>) avirulent mice, but <br />     peroxidase-type tryparedoxin peroxidases Trypanosoma brucei. J Biol Chem                   recover virulence prolonged culture vitro retaining pyrimidine <br />     280: 14385&#226;&#8364;&#8220;14394.                                                                             auxotrophy. Mol Microbiol 90: 443&#226;&#8364;&#8220;455. <br /> 24. Alibu VP, Storm L, Haile S, Clayton C, Horn D (2005) A doubly inducible                   53. Vigueira PA, Paul KS (2011) Requirement acetyl-CoA carboxylase in <br />     RNA interference rapid RNAi plasmid construction                            Trypanosoma brucei dependent growth environment. Mol <br />     Trypanosoma brucei. Mol Biochem Parasitol 139: 75&#226;&#8364;&#8220;82.                                         Microbiol 80: 117&#226;&#8364;&#8220;132. <br /> 25. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007)               54. Signorell A, Rauch M, Jelk J, Ferguson MA, Butikofer P (2008) Phosphatidyl- <br />     Clustal W Clustal X version 2.0. Bioinformatics 23: 2947&#226;&#8364;&#8220;2948.                            ethanolamine Trypanosoma brucei organized separate pools is <br /> 26. Bond CS, Schuttelkopf AW (2009) ALINE: WYSIWYG protein-sequence                             synthesized <br /> </body></html>